Research location

Camden

New Jersey, United States

Published trials266
Site observations272
Linked trials published266
Page2 / 6
Advertisement

Research activity in Camden

New Jersey, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 266 trials and 272 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Camden

266 linked trials · page 2 of 6
Open-label Trial in Parkinson's Disease (PD)NCT04760769 · 2021-02-24 · 1 site observation
COMPLETED
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialNCT04513717 · 2021-01-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR TrialNCT04402788 · 2021-01-07 · 1 site observation
SUSPENDED
Clinical Stabilization of Hypercapnia: NIPPV v HVNINCT04709562 · 2020-11-11 · 1 site observation
COMPLETED
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE StudyNCT04316117 · 2020-09-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung CancerNCT04214262 · 2020-08-13 · 1 site observation
ACTIVE_NOT_RECRUITING
RejuvenAir® System Trial for COPD With Chronic BronchitisNCT03893370 · 2020-07-09 · 1 site observation
UNKNOWN
NCI COVID-19 in Cancer Patients, NCCAPS StudyNCT04387656 · 2020-06-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialNCT04134260 · 2020-04-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Association of Hypertensive Disorder of Pregnancy With Sleep-disordered Breathing.NCT04126629 · 2020-01-22 · 1 site observation
UNKNOWN
Engaging Patients to Help Achieve Increased Patient Choice and Engagement for AFib Stroke PreventionNCT04096781 · 2019-12-18 · 1 site observation
COMPLETED
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant ChemotherapyNCT03872388 · 2019-09-23 · 1 site observation
TERMINATED
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node DissectionNCT03927027 · 2019-07-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid TumorsNCT03645928 · 2019-05-07 · 1 site observation
TERMINATED
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast CancerNCT03199885 · 2019-04-05 · 1 site observation
TERMINATED
Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR MutationNCT03833154 · 2019-03-06 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)NCT03740165 · 2018-12-18 · 1 site observation
COMPLETED
A Study to Test Radium-223 With Docetaxel in Patients With Prostate CancerNCT03574571 · 2018-06-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 2 site observations
COMPLETED
A Phase 3 Study With P2B001 in Subjects With Early Parkinson'sNCT03329508 · 2018-01-19 · 1 site observation
COMPLETED
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsNCT03170960 · 2017-09-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Continued Access Protocol for the Evaluation of the OPTIMIZER Smart SystemNCT03102437 · 2017-07-01 · 1 site observation
TERMINATED
Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed DyslipidemiaNCT02833844 · 2017-05-22 · 1 site observation
COMPLETED
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart FailureNCT03035474 · 2017-04-21 · 1 site observation
COMPLETED
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) StudyNCT03152292 · 2017-03-30 · 1 site observation
TERMINATED
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast CancerNCT03077841 · 2017-03-06 · 1 site observation
SUSPENDED
Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast CancerNCT02912312 · 2017-02-23 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)NCT03033511 · 2017-02-07 · 1 site observation
TERMINATED
A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's DiseaseNCT03034564 · 2017-01-01 · 1 site observation
TERMINATED
Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate CancerNCT02799602 · 2016-11-30 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive ParticipantsNCT02938520 · 2016-10-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain MetastasesNCT02595905 · 2016-09-15 · 1 site observation
COMPLETED
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)NCT02595944 · 2016-07-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).NCT02831959 · 2016-07-01 · 1 site observation
COMPLETED
Educational Videos to Address Racial Disparities in Implantable Cardioverter Defibrillator TherapyNCT02819973 · 2016-07-01 · 1 site observation
COMPLETED
Insomnia Interventions in Cancer SurvivorsNCT02783079 · 2016-05-01 · 1 site observation
UNKNOWN
Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.NCT02554890 · 2016-04-29 · 1 site observation
COMPLETED
An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's DiseaseNCT03034538 · 2016-04-08 · 1 site observation
SUSPENDED
Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate CancerNCT02615067 · 2015-12-01 · 1 site observation
COMPLETED
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusNCT02465515 · 2015-07-01 · 1 site observation
COMPLETED
Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)NCT02429791 · 2015-04-14 · 1 site observation
COMPLETED
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)NCT02381457 · 2015-04-01 · 1 site observation
COMPLETED
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected AdultsNCT02344290 · 2015-03-26 · 1 site observation
COMPLETED
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)NCT02201992 · 2015-03-23 · 1 site observation
ACTIVE_NOT_RECRUITING
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)NCT02193282 · 2015-02-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis TrialNCT02089217 · 2014-12-09 · 1 site observation
COMPLETED
Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former SmokersNCT02264990 · 2014-09-30 · 1 site observation
COMPLETED
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738 · 2014-09-26 · 1 site observation
ACTIVE_NOT_RECRUITING
LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)NCT02187783 · 2014-08-25 · 1 site observation
COMPLETED
DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac AmyloidosisNCT02252653 · 2014-06-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.